Sage CEO Barry Greene at Endpoints #JPM23 (Adrien Villez for Endpoints News)
Sage turns down Biogen's buyout offer and will look at other options
Sage Therapeutics knows it needs to do something. But it doesn’t want to sell to its partner Biogen.
On Monday, the troubled biotech said its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
